Towards elimination of HPV related diseases and cancers: An update on HPV vaccination.
Tuesday, September 19, 2023 |
7:30 AM - 9:00 AM |
Details
2023 has seen several changes to HPV vaccination in Australia; from changes in recommended dosing schedule, to expansion of the funded catch-up program to include those under 26 years of age and alignment of the registered age indication for Gardasil 9® (Human Papillomavirus 9-valent Vaccine, Recombinant) in males and females 9-45 years. This symposium brings together a diverse group of experts to discuss these changes and the potential opportunities they offer to further reduce HPV-related morbidity and mortality, with the ultimate goal being the elimination of cervical cancer and HPV-related disease.
Speaker
Dr Dorothy Machalek
Senior Research Fellow
The Kirby Institite
HPV vaccination in Australia – Key changes and new opportunities
Biography
Dr Dorothy Machalek is a Senior Research Fellow at the Kirby Institute and an Honorary Research Fellow with the Centre for Women’s Infectious Disease at The Royal Women’s Hospital in Melbourne. She holds a Doctorate in epidemiology and a Master of Public Health from the University of New South Wales. Her research focuses on the development and implementation of novel public health surveillance systems, and the evaluation of vaccination and screening strategies for the prevention of HPV and related diseases. Dr Machalek has led the development and implementation of a Commonwealth Department of Health-funded National HPV Monitoring Program (called IMPACT), the methodology of which has underpinned the design of a world-first project to evaluate the impact of one and two-dose HPV vaccine schedules in South Africa funded by NHMRC and the Bill and Melinda Gates Foundation.
Professor Andrew Grulich
Professor and Program Head HIV Epidemiology and Prevention Program
Kirby Institute
Is the elimination of HPV-related disease and cancers achievable in males?
Biography
Professor Andrew Grulich is a medical epidemiologist and Public Health Physician. He is head of the HIV Epidemiology and Prevention Program at the Kirby Institute, UNSW Australia. He is a governing council member of the International AIDS Society. His research interests include the links between infection, immune function and cancer; and the transmission and prevention of HIV and sexually transmitted infections in homosexual men. He was principal investigator of the Study of Prevention of Anal Cancer (SPANC), a cohort study investigating anal cancer screening
Terri Foran
Royal Hospital for Women (NSW) and University of NSW
Beyond the School Based Vaccination Program: A Clinician’s perspective
Biography
Dr Terri Foran is a Sexual Health Physician and has a special interest in contraception, menopause issues and the management of sexually transmitted infections. She is presently engaged in both clinical and research work at the Royal Hospital for Women in Sydney. Dr Foran holds the position of Conjoint Senior Lecturer at the University of New South Wales in the School of Women’s and Children’s Health.